Clinical trial
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or…
NCT00016432 · NSABP Foundation Inc, Other · Completed
Key facts
| NCT number | NCT00016432 |
|---|---|
| Title | Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen |
| Official title | A Randomized Trial Evaluating The Effect Of Exemestane In Clinical Stage T1-3 N0-1 M0 Postmenopausal Breast Cancer Patients Completing At Least Five Years Of Tamoxifen Therapy |
| Lead sponsor | NSABP Foundation Inc, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | exemestane, Placebo |
| Enrollment | 1,598 |
| Start date | May 1, 2001 |
| Primary completion | Oct 1, 2003 |
| Completion | Feb 1, 2011 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 19, 2011 |
| Countries | Canada, Puerto Rico, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: